Steve Kelly

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab

Nancy U. Lin, Eric P. Winer, Duncan Wheatley et al. · Breast Cancer Research and Treatment · 2012 · 194 citations · Full text

Tumour inoculation during laparoscopy

N. O’Rourke, P. Price, Steve Kelly et al. · The Lancet · 1993 · 142 citations

Medicine, Surgery, Surgical Oncology +1

Radiation pneumonitis in patients treated for breast cancer

R.I. Rothwell, Steve Kelly, C. A. Joslin · Radiotherapy and Oncology · 1985 · 121 citations

Radiation Therapy, Medicine, Brachytherapy +4

Palliation of obstructive nephropathy due to malignancy

Kevin J. Harrington, Hardev Pandha, Steve Kelly et al. · British Journal of Urology · 1995 · 44 citations

Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium

Robert Hettle, Hanne Wouters, Jon G. Ayres et al. · Respiratory Medicine · 2012 · 25 citations

Cost-utility Analysis, Healthcare Value, Health Policy +11